These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 15366332)

  • 21. Efficacy and safety of a combination herbal medicinal product containing Tropaeoli majoris herba and Armoraciae rusticanae radix for the prophylactic treatment of patients with respiratory tract diseases: a randomised, prospective, double-blind, placebo-controlled phase III trial.
    Fintelmann V; Albrecht U; Schmitz G; Schnitker J
    Curr Med Res Opin; 2012 Nov; 28(11):1799-807. PubMed ID: 23083066
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Immunologic indicators in the treatment of recurrent respiratory diseases using peroral bacterial vaccines].
    Kapellerová A; Sulko M; Krovinová A; Jakubovská M; Michalicková J; Mazáriková O
    Cesk Pediatr; 1989 Aug; 44(8):454-8. PubMed ID: 2791096
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Treatment with Lantigen B of chronic sinusitis in adults].
    Biernacik I
    Otolaryngol Pol; 1971; 25(2):219-22. PubMed ID: 5577925
    [No Abstract]   [Full Text] [Related]  

  • 24. Effectiveness of Polyvalent Bacterial Lysate and Autovaccines Against Upper Respiratory Tract Bacterial Colonization by Potential Pathogens: A Randomized Study.
    Zagólski O; Stręk P; Kasprowicz A; Białecka A
    Med Sci Monit; 2015 Oct; 21():2997-3002. PubMed ID: 26434686
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Recurrent respiratory diseases in young children and the value of nonspecific immunostimulation in the prevention and treatment of such diseases].
    Herzovi F
    Rev Pediatr Obstet Ginecol Pediatr; 1978; 27(3):245-8. PubMed ID: 103162
    [No Abstract]   [Full Text] [Related]  

  • 26. Strategies for optimizing compliance of paediatric patients for seasonal antibacterial vaccination with sublingually administered Polyvalent Mechanical Bacterial Lysates (PMBL).
    Rosaschino F; Cattaneo L
    Acta Biomed; 2004 Dec; 75(3):171-8. PubMed ID: 15796091
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The clinical and immunological efficacy of a combination of immunoglobulins and an oral polyvalent antibacterial vaccine in recurrent respiratory infections].
    Guerra E; Papetti C; Rosso R; Visconti E; Aiuti F
    Clin Ter; 1992 Jan; 140(1):33-41. PubMed ID: 1526096
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Assessment of salivary IgA titer in children with recurrent respiratory infections treated with polyvalent oral vaccine. A controlled study].
    Cimadamore N; Agriesti G; Testa A; Borgarello R; Capo G; Crua G
    Minerva Pediatr; 1988 Jun; 40(6):355-60. PubMed ID: 3054472
    [No Abstract]   [Full Text] [Related]  

  • 29. Treatment of recurrent respiratory tract infections with a polyvalent bacterial lysate: results of an open, prospective, multinational study.
    Grevers G; Palacios OA; Rodriguez B; Abel S; van Aubel A
    Adv Ther; 2000; 17(2):103-16. PubMed ID: 11010054
    [TBL] [Abstract][Full Text] [Related]  

  • 30. OM-85 BV: primary versus secondary prevention.
    Collet JP; Boissel JP
    Respiration; 1994; 61 Suppl 1():20-3. PubMed ID: 7800967
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and safety of pidotimod in the prevention of recurrent respiratory infections in children: a multicentre study.
    Namazova-Baranova LS; Alekseeva AA; Kharit SM; Kozhevnikova TN; Taranushenko TE; Tuzankina IA; Scarci F
    Int J Immunopathol Pharmacol; 2014; 27(3):413-9. PubMed ID: 25280032
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pidotimod for the prevention of acute respiratory infections in healthy children entering into daycare: A double blind randomized placebo-controlled study.
    Mameli C; Pasinato A; Picca M; Bedogni G; Pisanelli S; Zuccotti GV;
    Pharmacol Res; 2015 Jul; 97():79-83. PubMed ID: 25931316
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Primary prevention of acute respiratory tract infections in children using a bacterial immunostimulant: a double-masked, placebo-controlled clinical trial.
    Jara-Pérez JV; Berber A
    Clin Ther; 2000 Jun; 22(6):748-59. PubMed ID: 10929921
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical and therapeutical correlations in Moraxella catarrhalis respiratory infection in children].
    Goţia S; Coman G; Murgu A; Moraru E; Badiu I; Popa FC
    Pneumologia; 2001; 50(4):220-4. PubMed ID: 11977497
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Prevention and treatment of secondary infections in tracheotomized patients on artificial respiration (author's transl)].
    Marton E; Beus I; Rulnjevic J
    Lijec Vjesn; 1976 Sep; 98(9):491-3. PubMed ID: 1011925
    [No Abstract]   [Full Text] [Related]  

  • 36. [Immunoglobulin prophylaxis of recurrent infectious syndromes of the main respiratory passages].
    Melino C
    Nuovi Ann Ig Microbiol; 1977; 28(5):347-62. PubMed ID: 617864
    [No Abstract]   [Full Text] [Related]  

  • 37. Efficacy and safety of inhaled zanamivir in the prevention of influenza in community-dwelling, high-risk adult and adolescent subjects: a 28-day, multicenter, randomized, double-blind, placebo-controlled trial.
    LaForce C; Man CY; Henderson FW; McElhaney JE; Hampel FC; Bettis R; Kudule L; Harris J; Yates P; Tisdale M; Webster A
    Clin Ther; 2007 Aug; 29(8):1579-90; discussion 1577-8. PubMed ID: 17919541
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Oral polyvalent bacterial vaccine in children with recurrent respiratory infections].
    Oggiano N; Di Girolamo F; Salvucci C; Marinelli M; Gentili A; Pecora R; Orazi L; Catassi C
    Minerva Pediatr; 1985 Oct; 37(19):741-5. PubMed ID: 4088177
    [No Abstract]   [Full Text] [Related]  

  • 39. Evaluation trial of respiratory bacterial prophylaxis by a ribosomal vaccine. Multicentric double blind study.
    Fumex JP; Michel FB
    Arzneimittelforschung; 1980; 30(1a):206-13. PubMed ID: 6989376
    [No Abstract]   [Full Text] [Related]  

  • 40. [Lantigen B in the therapy of the upper respiratory tract diseases in children].
    Wróblewski W
    Przegl Lek; 1967; 23(3):346-9. PubMed ID: 6031065
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.